Sign in

Jacobs Solutions Inc. J

Price 147.1 USD
as of 2026-09-03
43/100
Mixed
Quality42
Growth28
Balance-sheet strength54
Valuation37
Momentum52
Income44

Composite 43/100; the shares have moved about 31% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Growth ranks 28/100 — a moderate mark against it.

Case for

Balance-sheet strength ranks 54/100 — a slight point in its favour. Momentum ranks 52/100 — a slight point in its favour.

Case against

Growth ranks 28/100 — a moderate mark against it. Valuation ranks 37/100 — a moderate mark against it. Quality ranks 42/100 — a slight mark against it.

What the company does Jacobs Solutions Inc. provides consulting, design, engineering, and infrastructure delivery services across sectors including energy, health sciences, transport, and defense. It operates globally with long-term facility operations and project management capabilities.

Key financials Profitability is modest: ROE 8%, ROA 4.5%, ROCE 8.6%. Margins show gross 22.1%, operating 7.4%, net 2.4%. Revenue grew 4.6% but EPS fell -6.7%. Leverage is elevated: Debt/Equity 1.25, Net debt/EBITDA 2.72.

Stock health Sideravia scores the stock Weak overall (43.4/100): Quality 41.4, Growth 32.1, Valuation 37.6. Momentum is mixed: 3m +32.02%, 12m +3.48%, RSI 69.40. Income yield is 1.0% with a 20.4% payout ratio.

Price vs fair value The stock trades at a discount of 8.30% versus the analyst mean target of 162.53. - Trading 9% below fair value after a $750 million Utah win (Simply Wall St.) - Recent Utah Canal Modernization Project adds near-term revenue visibility (Simply Wall St.) - Included among S&P 500 stocks with open questions (StockStory) - Nuclear cleanup services cited as a potential growth avenue (Zacks)

Looking forward Forward P/E of 17.70 and PEG of 0.10 suggest valuation support, but weak growth and high leverage remain risks. Analysts point to project wins as a potential catalyst for multiple expansion.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.